Elevate Chicago
CJC-1295 without DAC / Ipamorelin
No-DAC formulation unconfirmed$250
Patient price $250 for the 4 mg/4 mg preparation. Ordering is disabled until the supplier confirms the no-DAC formulation.
The requested preparation is CJC-1295 without DAC combined with ipamorelin, not standalone CJC-1295 and not a DAC-containing preparation.
The recorded supplier injection contains CJC-1295 2,000 mcg/mL and ipamorelin 2,000 mcg/mL in 2 mL (4 mg of each), but the listing does not specify DAC. The supplier must confirm the exact no-DAC preparation before it can be offered.
This combination is not an FDA-approved medication. Current clinical and pharmacy requirements must also be verified. It is not currently available to order.
If this preparation becomes available, it will be dispensed only after lab work and a consultation with the Elevate Chicago care team, pursuant to a patient-specific prescription, and filled by a licensed 503A compounding pharmacy. A prescription is not guaranteed.
This compounded product has not been reviewed, approved, or evaluated by the Food and Drug Administration for safety and effectiveness.